Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Hemasphere|March 17, 2022
External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort StudyNicolas Fattinger, Jan A Roth, Helen Baldomero, et al.
Chest|December 25, 2017
Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell TransplantationSylvia Nyilas, Luzia Baumeler, Michael Tamm, et al.
Journal of Clinical Lipidology|January 10, 2018
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up dataMelanie Premstaller, Melanie Perren, Kuebra Koçack, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 14, 2021
Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantationMichelle Bräutigam, Thomas Volken, Alexandra Plattner, et al.
Transplantation and Cellular Therapy|July 27, 2021
Transfusions in Aplastic Anemia Patients Cause HLA Alloimmunization: Comparisons of Current and Past Cohorts Demonstrate ProgressKatja Julen, Thomas Volken, Andreas Holbro, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute LeukemiaFranziska C Adam, Jakub Szybinski, Jörg P Halter, et al.
Transfusion|October 16, 2020
Adverse event reporting for cellular therapy products: Current status and future directionsKathy Loper, Michele W Sugrue, Jay S Raval, et al.
Bone Marrow Transplantation|January 14, 2025
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysisSilke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter, et al.
Clinical Pharmacology and Therapeutics|June 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational StudyJérémie Tachet, Sara C Meyer, Francesco Grandoni, et al.
Hematological Oncology|December 7, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Pageof 4